Cytodyn Inc (CYDY)

[Blane]

And I can’t believe how many phds on Twitter that brush leronlimab off, but haven’t looked into it. I tweeted a reply to Robert Kruse, PhD as he was actually tweeting about mABs in Covid. Asked if he had heard of Leronlimab? Nope. But instead of saying he would outrightly look into it, he “ I haven't looked at it. CCR5 antagonist. My personal preference at this point would be to target the virus itself as much as possible, since targeting specific immune pathways is complicated given our limited understanding, lower probability of success.”

How can you brush off Leronlimab without ACTUALLY researching its various, safe, and effective MOA?! That’s why this trial is so important right now. It’s the benchmark of the scientific process, and we as a company and shareholders need data. Simply relying on scientists outside of our circle to consider Leronlimab is apparently asking too much. Doesn’t matter though. The data will become undeniable.